[{"id":"9eb5d6d7-ad8d-4ee0-8b18-bf251243378d","acronym":"SPAG5","url":"https://clinicaltrials.gov/study/NCT04277195","created_at":"2021-01-18T20:46:22.425Z","updated_at":"2024-07-02T16:36:49.785Z","phase":"","brief_title":"Developing a Diagnostic Tool to Predict Response to Chemotherapy","source_id_and_acronym":"NCT04277195 - SPAG5","lead_sponsor":"Nottingham University Hospitals NHS Trust","biomarkers":" HER-2 • ER • SPAG5","pipe":"","alterations":" ","tags":["HER-2 • ER • SPAG5"],"overall_status":"Unknown status","enrollment":" Enrollment 4750","initiation":"Initiation: 11/07/2019","start_date":" 11/07/2019","primary_txt":" Primary completion: 05/31/2021","primary_completion_date":" 05/31/2021","study_txt":" Completion: 05/31/2021","study_completion_date":" 05/31/2021","last_update_posted":"2020-02-20"}]